Hepatitis C virus-associated extrahepatic manifestations: A review

Metabolic Brain Disease

Volumn 19, Issue 3-4, 2004, Pages 357-381

  Sène, Damien ^a   Limal, Nicolas ^a   Cacoub, Patrice ^a  

^a Paris Cedex 13 France ^*  (France)

Author keywords

cryoglobulinemia; extrahepatic manifestations; fatigue; Hepatitis C virus; lymphoma; neuropathy; vasculitis

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEGINTERFERON; RIBAVIRIN; STEROID; VIRUS ANTIBODY;

ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; CHRONIC ACTIVE HEPATITIS; CONFERENCE PAPER; CORNEA RODENT ULCER; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG EFFICACY; ENCEPHALOMYELITIS; ERYTHEMA NODOSUM; FATIGUE; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; KIDNEY DISEASE; LICHEN PLANUS; LIVER CIRRHOSIS; LUNG FIBROSIS; LYMPHOPROLIFERATIVE DISEASE; NEURITIS; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHODGKIN LYMPHOMA; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PLASMAPHERESIS; POLYARTERITIS NODOSA; POLYMYOSITIS; PORPHYRIA CUTANEA TARDA; PRURITUS; RHEUMATOLOGY; SJOEGREN SYNDROME; SKIN DISEASE; THROMBOCYTOPENIA; THYROIDITIS; VASCULITIS; VIRUS REPLICATION;

AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; FATIGUE; HEPATITIS C; HUMANS; LYMPHOMA; PERIPHERAL NERVOUS SYSTEM DISEASES; SJOGREN'S SYNDROME; VASCULITIS;

HEPATITIS C VIRUS; RNA VIRUSES; RODENTIA;

EID: 5444245634     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000043982.17294.9b     Document Type: Conference Paper

References (219)

1. Adartis, E., Cacoub, P., Musset, L., Fabiani, P.L., Caen, O.L., Godeau, P., Boche, P., and Leger, J.M. (1993). Peripheral neuropathies in essential mixed cryoglobulinemia: Influence of positive serology for hepatitis C virus. Rev. Med. Interne 14:1008.
2. Adinolfi, L.E., Utili, R., Zampino, R., Ragone, E., Mormone, G., and Ruggiero, G. (1997). Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. Eur. J. Gastroenterol. Hepatol. 9:1067-1072.
3. Agnello, V., Chung, R.T., and Kaplan, L.M. (1992). A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490-1495.
4. Agnello, V., Zhang, Q.X., Abel, G., and Knight, G.B. (1995). The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: Implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl. 13):S101-S104.
5. Akriviadis, E.A., Xanthakis, I., Navrozidou, C., and Papadopoulos, A. (1997). Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J. Clin. Gastroenterol. 25:612-618.
6. Alric, L., Plaisier, E., Thebault, S., Peron, J.M., Rostaing, L., Tourrat, J., Ronco, P., Piette, J.C., and Cacoub, P. (2004). Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am. J. Kidney Dis. 43:617-623.
7. Amoroso, A., Berrino, M., Canale, L., Cornaglia, M., Guarrera, S., Mazzola, G., Savoldi, S., Scolari, F., Sallberg, M., Clementi, M., and Gabrielli, A. (1998). Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? J. Hepatol. 29:36-44.
8. Andreone, P., Cursaro, C., Gramenzi, A., Guidetti, M.S., Bardazzi, F., Tosti, A., and Miniero, R. (1995). Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanea tarda. Hepatology 21:1754-1755.
9. Apartis, E., Leger, J.M., Musset, L., Gugenheim, M., Cacoub, P., Lyon-Caen, O., Pierrot-Deseilligny, C., Hauw, J.J., and Bouche, P. (1996). Peripheral neuropathy associated with essential mixed cryoglobulinaemia: A role for hepatitis C virus infection? J. Neurol. Neurosurg. Psychiatry 60:661-666.
10. Arao, M., Murase, K., Kusakabe, A., Yoshioka, K., Fukuzawa, Y., Ishikawa, T., Tagaya, T., Yamanouchi, K., Ichimiya, H., Sameshima, Y., and Kakumu, S. (2003). Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J. Gastroenterol. 38:355-360.
11. Authier, F.J., Bassez, G., Payan, C., Guillevin, L., Pawlotsky, J.M., Degos, J.D., Gherardi, R.K., and Belec, L. (2003). Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 60:808-812.
12. Bauduer, F., Katsahian, S., Blanchard, Y., Oui, B., Capdupuy, C., and Renoux, M. (1999). Descriptive epidemiology of non-Hodgkin lymphomas in a southwestern French hematology center: Absence of significant relationship with hepatitis C virus infection. Hematol. Cell Ther. 41:191-193.
13. Beddhu, S., Bastacky, S., and Johnson, J.P. (2002). The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81:398-409.
14. Bombardieri, S., Ferri, C., Di Munno, O., and Pasero, G. (1979). Liver involvement in essential mixed cryoglobulinemia. Ric. Clin. Lab. 9:361-368.
15. Bonetti, B., Scardoni, M., Monaco, S., Rizzuto, N., and Scarpa, A. (1999). Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch. 434:533-535.
16. Bonkovsky, H.L., and Barnard, G.F. (2000). The porphyrias. Curr. Treat Options Gastroenterol. 3:487-500.
17. Bonkovsky, H.L., Poh-Fitzpatrick, M., Pimstone, N., Obando, J., Di Bisceglie, A., Tattrie, C., Tortorelli, K., LeClair, P., Mercurio, M.G., and Lambrecht, R.W. (1998). Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 27:1661-1669.
18. Brind, A.M., Watson, J.P., Burt, A., Kestevan, P., Wallis, J., Proctor, S.J., and Bassendine, M.F. (1996). Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma. 21:127-130.
19. Brouet, J.C., Clauvel, J.P., Danon, F., Klein, M., and Seligmann, M. (1974). Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 57:775-788.
20. Bruchfeld, A., Lindahl, K., Stahle, L., Soderberg, M., and Schvarcz, R. (2003). Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol. Dial. Transplant. 18:1573-1580.
21. Buskila, D., Shnaider, A., Neumann, L., Lorber, M., Zilberman, D., Hilzenrat, N., Kuperman, O.J., and Sikuler, E. (1998). Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin. Arthritis Rheum. 28:107-113.
22. Cacoub, P., Lunel-Fabiani, F., and Du, L.T. (1992). Polyarteritis nodosa and hepatitis C virus infection. Ann. Intern. Med. 116:605-606.
23. Cacoub, P., Musset, L., Lunel Fabiani, F., Perrin, M., Leger, J.M., Thi Huong Du, L., Wechsler, B., Bletry, O., Opolon, P., Huraux, J.M., JC., P., and Godeau, P. (1993). Hepatitis C virus and essential mixed cryoglobulinaemia. Br. J. Rheumatol. 32:689-692.
24. Cacoub, P., Fabiani, F.L., Musset, L., Perrin, M., Frangeul, L., Leger, J.M., Huraux, J.M., Piette, J.C., and Godeau, P. (1994a). Mixed cryoglobulinemia and hepatitis C virus. Am. J. Med. 96:124-132.
25. Cacoub, P., Noel, L.H., Musset, L., Lunel, F., Opolon, P., and Piette, J.C. (1994b). Anti-neutrophil cytoplasmic antibodies and mixed cryoglobulinemia. Clin. Exp. Rheumatol. 12:693.
26. Cacoub, P., Musset, L., Amoura, Z., Guilani, P., Chabre, H., Lunel, F., Poynard, T., Opolon, P., and Piette, J.C. (1997). Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. J. Rheumatol. 24:2139-2144.
27. Cacoub, P., Ghillani, P., Revelen, R., Thibault, V., Calvez, V., Charlotte, F., Musset, L., Youinou, P., and Piette, J.C. (1999a). Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia. J. Hepatol. 31:598-603.
28. Cacoub, P., Poynard, T., Ghillani, P., Charlotte, F., Olivi, M., Piette, J.C., and Opolon, P. (1999b). Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 42:2204-2212.
29. Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., Yamamoto, A.M., Camproux, A.C., Hausfater, P., Musset, L., Veyssier, P., Raguin, G., and Piette, J.C. (2000). Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 79:47-56.
30. Cacoub, P., Renou, C., Kerr, G., Hue, S., Rosenthal, E., Cohen, P., Kaplanski, G., Charlotte, F., Thibault, V., Ghillani, P., Piette, J.C., and Caillat-Zucman, S. (2001). Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum. 44:2118-2124.
31. Cacoub, P., Lidove, O., Maisonobe, T., Duhaut, P., Thibault, V., Ghillani, P., Myers, R.P., Leger, J.M., Servan, J., and Piette, J.C. (2002a). Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 46:3317-3326.
32. Cacoub, P., Ratziu, V., Myers, R.P., Ghillani, P., Piette, J.C., Moussalli, J., and Poynard, T. (2002b). Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J. Hepatol. 36:812-818.
33. Cacoub, P., Bourliere, M., Hausfater, P., Charlotte, F., Khiri, H., Toci, S., Piette, J.C., Poynard, T., and Halfon, P. (2003). Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection. J. Viral Hepat. 10:10-15.
34. Calleja, J.L., Albillos, A., Moreno-Otero, R., Rossi, I., Cacho, G., Domper, F., Yebra, M., and Escartin, P. (1999). Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacot. Ther. 13:1179-1186.
35. Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B.D., and Alexander, G.J. (1999). Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30:1059-1063.
36. Carson, C.W., Conn, D.L., Czaja, A.J., Wright, T.L., and Brecher, M.E. (1993). Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J. Rheumatol. 20:304-309.
37. Casato, M., Agnello, V., Pucillo, L.P., Knight, G.B., Leoni, M., Del Vecchio, S., Mazzilli, C., Antonelli, G., and Bonomo, L. (1997). Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90:3865-3873.
38. Casato, M., Mecucci, C., Agnello, V., Fiorilli, M., Knight, G.B., Matteucci, C., Gao, L., and Kay, J. (2002). Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 99:2259-2261.
39. Casato, M., Saadoun, D., Marchetti, A., Piscq, C., Pantano, P., Dormont, D., Piatella, M.C., Duhaut, P., Ciancil, R., Fiorilli, M., Piette, J., and Cacoub, P. (2003). Central nervous system involvement in HCV-cryoglobulinemia vasculitis: A multicenter case-control study using MRI and neuropsychological tests. Arthritis Rheum. 48:S522.
40. Casato, M., Taliani, G., Pucillo, L.P., Goffredo, F., Lagana, B., and Bonomo, L. (1991). Cryoglobulinaemia and hepatitis C virus. Lancet 337:1047-1048.
41. Cavanna, L., Sbolli, G., Tanzi, E., Romano, L., Civardi, G., Buscarini, E., Vallisa, D., Berte, R., and Rossi, A. (1995). High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica 80:486-487.
42. Chen, L.K., Hwang, S.J., Tsai, S.T., Luo, J.C., Lee, S.D., and Chang, F.Y. (2003). Glucose intolerance in Chinese patients with chronic hepatitis C. World J. Gastroenterol. 9:505-508.
43. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
44. Cicardi, M., Cesana, B., Del Ninno, E., Pappalardo, E., Silini, E., Agostoni, A., and Colombo, M. (2000). Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J. Viral Hepat. 7:138-143.
45. Clifford, B.D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., and Bonkovsky, H.L. (1995). High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613-619.
46. Cohen, P., Nguyen, Q.T., Deny, P., Ferriere, F., Roulot, D., Lortholary, O., Jarrousse, B., Danon, F., Barrier, J.H., Ceccaldi, J., Constans, J., Crickx, B., Fiessinger, J.N., Hachulla, E., Jaccard, A., Seligmann, M., Kazatchkine, M., Laroche, L., Subra, J.F., Turlure, P., and Guillevin, L. (1996). Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients. Ann. Med. Interne (Paris) 147:81-86.
47. Congia, M., Clemente, M.G., Dessi, C., Cucca, F., Mazzoleni, A.P., Frau, F., Lampis, R., Cao, A., Lai, M.E., and De Virgiliis, S. (1996). HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 24:1338-1341.
48. Costa, J., Resende, C., and De Carvalho, M. (2003). Motor-axonal polyneuropathy associated with hepatitis C virus. Eur. J. Neurol. 10:183-185.
49. Cresta, P., Musset, L., Cacoub, P., Frangeul, L., Vitour, D., Poynard, T., Opolon, P., Nguyen, D.T., Golliot, F., Piette, J.C., Huraux, J.M., and Lunel, F. (1999). Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut 45:122-128.
50. Cribier, B., Petiau, P., Stoll-Keller, F., Schmitt, C., Vetter, D., Heid, E., and Grosshans, E. (1996b). [Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study]. Ann. Dermatol. Venereol. 123:200-202.
51. Cribier, B., Rey, D., Uhl, G., Le Coz, C., Hirth, C., Libbrecht, E., Vetter, D., Lang, J.M., Stoll-Keller, F., and Grosshans, E. (1996a). Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch. Dermatol. 132:1448-1452.
52. Crovatto, M., Ceselli, S., Mazzaro, C., Modolo, M.L., Martelli, P., Mazzi, G., Pozzato, G., Giannini, F., Barbisin, M., Chiarotto, B., and Santini, G. F. (1995). HCV genotypes and cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl. 13): S79-S82.
53. Crovatto, M., Pozzato, G., Zorat, F., Pussini, E., Nascimben, F., Baracetti, S., Grando, M.G., Mazzaro, C., Reitano, M., Modolo, M.L., Martelli, P., Spada, A., and Santini, G. (2000). Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 85:356-361.
54. D'Amico, G. (1998). Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int. 54:650-671.
55. D'Amico, G., and Fornasieri, A. (1995). Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus. Am. J. Kidney Dis. 25:361-369.
56. Dammacco, F., Gatti, P., and Sansonno, D. (1998). Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture. Leuk. Lymphoma 31:463-476.
57. Dammacco, F., Sansonno, D., Han, J.H., Shyamala, V., Cornacchiulo, V., Iacobelli, A.R., Lauletta, G., and Rizzi, R. (1994). Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study. Blood 84:3336-3343.
58. De Martino, L., Sampaolo, S., Tucci, C., Ambrosone, L., Budillon, A., Migliaresi, S., and Di Iorio, G. (2003). Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve 27:102-104.
59. De Re, V., De Vita, S., Marzotto, A., Gloghini, A., Pivetta, B., Gasparotto, D., Cannizzaro, R., Carbone, A., and Boiocchi, M. (2000). Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int. J. Cancer 87:211-216.
60. De Rosa, F.G., Pucillo, L.P., Coviello, R., Pirro, M.R., Fiaschetti, P., Candela, M., Gabrielli, A., Lagana, B., Fiorilli, M., and Casato, M. (2002). Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. Hum. Immunol. 63:751-757.
61. De Rosa, G., Gobbo, M.L., De Renzo, A., Notaro, R., Garofalo, S., Grimaldi, M., Apuzzo, A., Chiurazzi, F., Picardi, M., Matarazzo, M., and Rotoli, B. (1997). High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am. J. Hematol. 55:77-82.
62. Deny, P., Guillevin, L., Bonacorsi, S., and Quint, L. (1992). Association between hepatitis C virus and polyarteritis nodosa. Clin. Exp. Rheumatol. 10:319.
63. Dereure, O., Aguilar-Martinez, P., Bessis, D., Perney, P., Vallat, C., Guillot, B., Blanc, F., and Guilhou, J.J. (2001). HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: A prospective study of 36 cases from southern France. Br. J. Dermatol. 144:533-539.
64. Dienstag, J.L., Wands, J.R., and Isselbacher, K.J. (1977). Hepatitis B and essential mixed cryoglobulinemia. N. Engl. J. Med. 297:946-947.
65. Disdier, P., Harle, J.R., and Weiller, P.J. (1991). Cryoglobulinaemia and hepatitis C infection. Lancet 338:1151-1152.
66. Donada, C., Crucitti, A., Donadon, V., Tommasi, L., Zanette, G., Crovatto, M., Santini, G.F., Chemello, L., and Alberti, A. (1998). Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J. Viral Hepat. 5:179-185.
67. Dupin, N., Chosidow, O., Lunel, F., Cacoub, P., Musset, L., Cresta, P., Frangeul, L., Piette, J.C., Godeau, P., and Opolon, P. (1995). Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch. Dermatol. 131:1124-1127.
68. Egger, N.G., Goeger, D.E., Payne, D.A., Miskovsky, E.P., Weinman, S.A., and Anderson, K.E. (2002). Porphyria cutanea tarda: Multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig. Dis. Sci. 47:419-426.
69. El-Serag, H.B., Hampel, H., Yeh, C., and Rabeneck, L. (2002). Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36:1439-1445.
70. Espanol, I., Gallego, A., Enriquez, J., Rabella, N., Lerma, E., Hernandez, A., and Pujol-Moix, N. (2000). Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: Role of thrombopoietin. Hepatogastroenterology 47:1404-1406.
71. Fabrizi, F., Colucci, P., Ponticelli, C., and Locatelli, F. (2002). Kidney and liver involvement in cryoglobulinemia. Semin. Nephrol. 22:309-318.
72. Fabrizi, F., Pozzi, C., Farina, M., Dattolo, P., Lunghi, G., Badalamenti, S., Pagano, A., and Locatelli, F. (1998). Hepatitis C virus infection and acute or chronic glomerulonephritis: An epidemiological and clinical appraisal. Nephrol. Dial. Transplant. 13:1991-1997.
73. Fargion, S., Piperno, A., Cappellini, M.D., Sampietro, M., Fracanzani, A.L., Romano, R., Caldarelli, R., Marcelli, R., Vecchi, L., and Fiorelli, G. (1992). Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322-1326.
74. Fearon, D.T., and Carroll, M.C. (2000). Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393-422.
75. Ferri, C., Baicchi, U., la Civita, L., Greco, F., Longombardo, G., Mazzoni, A., Careccia, G., Bombardieri, S., Pasero, G., Zignego, A.L., et al. (1993). Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur. J. Clin. Invest. 23:851-855.
76. Ferri, C., Caracciolo, F., Zignego, A.L., La Civita, L., Monti, M., Longombardo, G., Lombardini, F., Greco, F., Capochiani, E., Mazzoni, A., Mazzaro, C., and Pasero, G. (1994). Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br. J. Haematol. 88:392-394.
77. Ferri, C., Greco, F., Longombardo, G., Palla, P., Moretti, A., Marzo, E., Fosella, P.V., Pasero, G., and Bombardieri, S. (1991a). Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 34:1606-1610.
78. Ferri, C., Greco, F., Longombardo, G., Palla, P., Moretti, A., Marzo, E., Mazzoni, A., Pasero, G., Bombardieri, S., Highfield, P., and Corbishley, T. (1991b). Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin. Exp. Rheumatol. 9:621-624.
79. Ferri, C., Zignego, A.L., and Pileri, S.A. (2002). Cryoglobulins. J. Clin. Pathol. 55:4-13.
80. Fornasieri, A., Li, M., Armelloni, S., de Septis, C.P., Schiaffino, E., Sinico, R.A., Schmid, C., and D'Amico, G. (1993). Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab. Invest. 69:531-540.
81. Fornasieri, A., Bernasconi, P., Ribero, M.L., Sinico, R.A., Fasola, M., Zhou, J., Portera, G., Tagger, A., Gibelli, A., and D'Amico, G. (2000). Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin. Exp. Immunol. 122:400-403.
82. Fornasieri, A., and D'Amico, G. (1996). Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol. Dial. Transplant. 11 (Suppl. 4):25-30.
83. Fracanzani, A.L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., and Fargion, S. (2001). Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J. Hepatol. 35:498-503.
84. Frangeul, L., Musset, L., Cresta, P., Cacoub, P., Huraux, J.M., and Lunel, F. (1996). Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J. Hepatol. 25:427-432.
85. Galli, M. (1991). Cryoglobulinaemia and serological markers of hepatitis viruses. Lancet 338:758-759.
86. Galli, M., Monti, G., Invemizzi, F., Monteverde, A., Bombardieri, S., Gabrielli, A., Migliaresi, S., Mussini, C., Ossi, E., Pietrogrande, M., et al. (1992). Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: A multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC). Ann. Ital. Med. Int. 7:209-214.
87. Giannelli, F., Moscarella, S., Giannini, C., Caini, P., Monti, M., Gragnani, L., Romanelli, R.G., Solazzo, V., Laffi, G., La Villa, G., Gentilini, P., and Zignego, A.L. (2003). Effect of antiviral treatment in patients with chronic HCV infection and t(14; 18) translocation. Blood 102:1196-1201.
88. Giannini, E., Borro, P., Botta, F., Fumagalli, A., Malfatti, F., Podesta, E., Romagnoli, P., Testa, E., Chiarbonello, B., Polegato, S., Mamone, M., and Testa, R. (2002). Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol. 37:572-577.
89. Gisbert, J.P., Garcia-Buey, L., Pajares, J.M., and Moreno-Otero, R. (2003a). Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: Systematic review and meta-analysis. Gastroenterology 125:1723-1732.
90. Gisbert, J.P., Garcia-Buey, L., Pajares, J.M., and Moreno-Otero, R. (2003b). Prevalence of hepatitis C virus infection in porphyria cutanea tarda: Systematic review and meta-analysis. J. Hepatol. 39:620-627.
91. Goh, J., Coughlan, B., Quinn, I., O'Keane, J.C., and Crowe, J. (1999). Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur. J. Gastroenterol. Hepatol. 11:833-838.
92. Gray, H., Wreghitt, T., Stratton, I.M., Alexander, G.J., Turner, R.C., and O'Rahilly, S. (1995). High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet. Med. 12:244-249.
93. Gumber, S.C., and Chopra, S. (1995). Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann. Intern. Med. 123:615-620.
94. Haddad, J., Deny, P., Munz-Gotheil, C., Ambrosini, J.C., Trinchet, J.C., Pateron, D., Mal, F., Callard, P., and Beaugrand, M. (1992). Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323.
95. Hausfater, P., Cacoub, P., Rosenthal, E., Bernard, N., Loustaud-Ratti, V., Le Lostec, Z., Laurichesse, H., Turpin, F., Ouzan, D., Grasset, D., Perrone, C., Cabrol, M.P., and Piette, J.C. (2000). Hepatitis C virus infection and lymphoproliterative diseases in France: A national study. The GERMIVIC Group. Am. J. Hematol. 64:107-111.
96. Hausfater, P., Cacoub, P., Sterkers, Y., Thibault, V., Amoura, Z., Nguyen, L., Ghillani, P., Leblond, V., and Piette, J.C. (2001). Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France. Am. J. Hematol. 67:168-171.
97. Heckmann, J.G., Kayser, C., Heuss, D., Manger, B., Blum, H.E., and Neundorfer, B. (1999). Neurological manifestations of chronic hepatitis C. J. Neurol. 246:486-491.
98. Hekali, P., Kajander, H., Pajari, R., Stenman, S., and Somer, T. (1991). Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol. 32:143-148.
99. Hermine, O., Lefrere, F., Bronowicki, J.P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., Varet, B., and Troussard, X. (2002). Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347:89-94.
100. Hernandez, F., Blanquer, A., Linares, M., Lopez, A., Tarin, F., and Cervero, A. (1998). Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol. 99:217-220.
101. Herrero, C., Vicente, A., Bruguera, M., Ercilla, M.G., Barrera, J.M., Vidal, J., Teres, J., Mascaro, J.M., and Rodes, J. (1993). Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341:788-789.
102. Hussain, I., Hepburn, N.C., Jones, A., O'Rourke, K., and Hayes, P.C. (1996). The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin. Exp. Dermatol. 21:283-285.
103. Ivanovski, M., Silvestri, F., Pozzato, G., Anand, S., Mazzaro, C., Burrone, O.R., and Efremov, D.G. (1998). Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91:2433-2442.
104. Izumi, T., Sasaki, R., Tsunoda, S., Akutsu, M., Okamoto, H., and Miura, Y. (1997). B cell malignancy and hepatitis C virus infection. Leukemia 11(Suppl. 3):516-518.
105. Jennette, J.C., and Falk, R.J. (1997). Small-vessel vasculitis. N. Engl. J. Med. 337:1512-1523.
106. Johnson, R.J., Gretch, D.R., Yamabe, H., Hart, J., Bacchi, C.E., Hartwell, P., Couser, W.G., Corey, L., Wener, M.H., Alpers, C.E., and Willson, R. (1993). Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328:465-470.
107. Jorgensen, C., Legouffe, M.C., Perney, P., Coste, J., Tissot, B., Segarra, C., Bologna, C., Bourrat, L., Combe, B., Blanc, F., and Sany, J. (1996). Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum. 39:1166-1171.
108. Kawasaki, T., Takeshita, A., Souda, K., Kobayashi, Y., Kikuyama, M., Suzuki, F., Kageyama, F., Sasada, Y., Shimizu, E., Murohisa, G., Koide, S., Yoshimi, T., Nakamura, H., and Ohno, R. (1999). Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am. J. Gastroenterol. 94:1918-1922.
109. Kayali, Z., Buckwold, V.E., Zimmerman, B., and Schmidt, W.N. (2002). Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis. Hepatology 36:978-985.
110. Kerr, G.S., Rofail, M., Lewis, J.H., Kumar, P., and Seeff, L.B. (1997). Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital. J. Rheumatol. 24:2134-2138.
111. King, P.D., Wilkes, J.D., and Diaz-Arias, A.A. (1998). Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin. Lab. Haematol. 20:107-110.
112. Kitay-Cohen, Y., Amiel, A., Hilzenrat, N., Buskila, D., Ashur, Y., Fejgin, M., Gaber, E., Safadi, R., Tur-Kaspa, R., and Lishner, M. (2000). Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96:2910-2912.
113. Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., and Schattner, A. (2000). Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin. Proc. 75:355-359.
114. Koester, G., Feldman, J., and Bigler, C. (1994). Hepatitis C in patients with porphyria cutanea tarda. J. Am. Acad. Dermatol. 31:1054.
115. Koike, K., Moriya, K., Ishibashi, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Kurokawa, K., Matsuura, Y., and Miyamura, T. (1997). Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc. Natl. Acad. Sci. U.S.A. 94:233-236.
116. Kondo, M., Horie, Y., Okano, J., Kitamura, A., Maeda, N., Kawasaki, H., Mishiro, S., Yamamoto, S., Itou, T., Saeki, S., Tanaka, S., and Okamoto, H. (1997). High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda. Hepatology 26:246.
117. Kuniyoshi, M., Nakamuta, M., Sakai, H., Enjoji, M., Kinukawa, N., Kotoh, K., Fukutomi, M., Yokota, M., Nishi, H., Iwamoto, H., Uike, N., Nishimura, J., Inaba, S., Maeda, Y., Nawata, H., and Muta, K. (2001). Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J. Gastroenterol. Hepatol. 16:215-219.
118. Lacaille, F., Zylberberg, H., Hagege, H., Roualdes, B., Meyrignac, C., Chousterman, M., and Girot, R. (1998). Hepatitis C associated with Guillain-Barre syndrome. Liver 18:49-51.
119. Lacour, J.P., Bodokh, I., Castanet, J., Bekri, S., and Ortonne, J.P. (1993). Porphyria cutanea tarda and antibodies to hepatitis C virus. Br. J. Dermatol. 128:121-123.
120. Lamoril, J., Andant, C., Gouya, L., Malonova, E., Grandchamp, B., Martasek, P., Deybac, J.C., and Puy, H. (2002). Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). Cell Mol. Biol. (Noisy-le-grand) 48:33-41.
121. Lamprecht, P., Lerin-Lozano, C., Merz, H., Dennin, R.H., Gause, A., Voswinkel, J., Peters, S.O., Gutzeit, O., Arlt, A.C., Solbach, W., and Gross, W.L. (2003). Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann. Rheum. Dis. 62:1230-1233.
122. Lauer, G.M., and Walker, B.D. (2001). Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
123. Lee, Y.H., Ji, J.D., Yeon, J.E., Byun, K.S., Lee, C.H., and Song, G.G. (1998). Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann. Rheum. Dis. 57:728-731.
124. Lenzi, M., Frisoni, M., Mantovani, V., Ricci, P., Muratori, L., Francesconi, R., Cuccia, M., Ferri, S., and Bianchi, F.B. (1998). Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 91:2062-2066.
125. Leone, N., Pellicano, R., Ariata Maiocco, I., Modena, V., Marietti, G., Rizzetto, M., and Ponzetto, A. (2002). Mixed cryoglobulinaemia and chronic hepatitis C virus infection: The rheumatic manifestations. J. Med. Virol. 66:200-203.
126. Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M.A., Trepo, C., and Inchauspe, G. (1998). In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype. Blood 91:3841-3849.
127. Levo, Y., Gorevic, P.D., Kassab, H.J., Tobias, H., and Franklin, E.C. (1977). Liver involvement in the syndrome of mixed cryoglobulinemia. Ann. Intern. Med. 87:287-292.
128. Lhote, F., and Guillevin, L. (1995). Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum. Dis. Clin. North Am. 21:911-947.
129. Lie, J.T. (1994). Nomenclature and classification of vasculitis: plus ca change, plus c'est la meme chose. Arthritis Rheum. 37:181-186.
130. Lopez Morante, A., Saez-Royuela, F., Martin Lorente, J.L., Yuguero del Moral, L., and Ojeda Gimenez, C. (1995). Hepatitis C virus infection and porphyria cutanea tarda. Gastroenterol. Hepatol. 18:7-10.
131. Loustaud-Ratti, V., Riche, A., Liozon, E., Labrousse, F., Soria, P., Rogez, S., Babany, G., Delaire, L., Denis, F., and Vidal, E. (2001). Prevalence and characteristics of Sjogren's syndrome or sicca syndrome in chronic hepatitis C virus infection: A prospective study. J. Rheumatol. 28:2245-2251.
132. Lunel, F., Musset, L., Cacoub, P., Frangeul, L., Cresta, P., Perrin, M., Grippon, P., Hoang, C., Valla, D., Piette, J.C., Huraux, J.M., and Opolon, P. (1994). Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300.
133. Luppi, M., Grazia Ferrari, M., Bonaccorsi, G., Longo, G., Narni, F., Barozzi, P., Marasca, R., Mussini, C., and Torelli, G. (1996). Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 10:351-355.
134. Mancini, C., Griso, D., Rivanera, D., Macri, A., Casino, C., and Lilli, D. (1998). Porphyria cutanea tarda and hepatitis G and C virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 17:534-535.
135. Marcellin, P., Descamps, V., Martinot-Peignoux, M., Larzul, D., Xu, L., Boyer, N., Pham, B.N., Crickx, B., Guillevin, L., Belaich, S., Erlinger, S., and Benhamous, J. P. (1993). Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272-277.
136. Mason, A.L., Lau, J.Y., Hoang, N., Qian, K., Alexander, G.J., Xu, L., Guo, L., Jacob, S., Regenstein, F.G., Zimmerman, R., Everhart, J.E., Wasserfall, C., Maclaren, N.K., and Perrillo, R.P. (1999). Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-333.
137. Mayo, M.J. (2003). Extrahepatic manifestations of hepatitis C infection. Am. J. Med. Sci. 325:135-148.
138. Mazzaro, C., Panarello, G., Tesio, F., Santini, G., Crovatto, M., Mazzi, G., Zorat, F., Tulissi, P., Pussini, E., Baracetti, S., Campanacci, L., and Pozzato, G. (2000). Hepatitis C virus risk: A hepatitis C virus related syndrome. J. Intern. Med. 247:535-545.
139. Mazzaro, C., Pozzato, G., Zorat, F., Panarello, G., Silvestri, F., Barillari, G., Mazzoran, L., Baracetti, S., Crovatto, M., Santini, G.F., Donadon, V., Faccini, L., and Campanacci, L. (1999). Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection. Ital. J. Gastroenterol. Hepatol. 31:45-53.
140. Mazzaro, C., Tulissi, P., Moretti, M., Mazzoran, L., Pussini, E., Crovatto, M., Santini, G.F., and Pozzato, G. (1995). Clinical and virological findings in mixed cryoglobulinaemia. J. Intern. Med. 238:153-160.
141. Mazzaro, C., Zagonel, V., Monfardini, S., Tulissi, P., Pussini, E., Fanni, M., Sorio, R., Bortolus, R., Crovatto, M., Santini, G., Tiribelli, C., Sasso, F., Masutti, R., and Pozzato, G. (1996). Hepatitis C virus and non-Hodgkin's lymphomas. Br. J. Haematol. 94:544-550.
142. Mazzaro, C., Zorat, F., Comar, C., Nascimben, F., Bianchini, D., Baracetti, S., Donada, C., Donadon, V., and Pozzato, G. (2003). Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J. Rheumatol. 30:1775-1781.
143. McColl, M.D., Singer, I.O., Tait, R.C., McNeil, I.R., Cumming, R.L., and Hogg, R.B. (1997). The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma - A regional association? Leuk. Lymphoma 26:127-130.
144. Mele, A., Pulsoni, A., Bianco, E., Musto, P., Szklo, A., Sanpaolo, M.G., Iannitto, E., De Renzo, A., Martino, B., Liso, V., Andrizzi, C., Pusterla, S., Dore, F., Maresca, M., Rapicetta, M., Marcucci, F., Mandelli, F., and Franceschi, S. (2003). Hepatitis C virus and B-cell non-Hodgkin lymphomas: An Italian multicenter case-control study. Blood 102:996-999.
145. Meltzer, M., Franklin, E.C., Elias, K., McCluskey, R.T., and Cooper, N. (1966). Cryoglobulinemia - A clinical and laboratory study. II: Cryoglobulins with rheumatoid factor activity. Am. J. Med. 40:837-856.
146. Migliaresi, S., Di Iorio, G., Ammendola, A., Ambrosone, L., Sanges, G., Ugolini, G., Sampaolo, S., Bravaccio, F., and Tirri, G. (2001). Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia. Reumatismo 53:26-32.
147. Migliaresi, S., and Tirri, G. (1995). Interferon in the treatment of mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl. 13) :S175-S180.
148. Misiani, R., Bellavita, P., Fenili, D., Borelli, G., Marchesi, D., Massazza, M., Vendramin, G., Comotti, B., Tanzi, E., and Scudeller, G. (1992). Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann. Intern. Med. 117:573-577.
149. Misiani, R., Bellavita, P., Fenili, D., Vicari, O., Marchesi, D., Sironi, P.L., Zilio, P., Vernocchi, A., Massazza, M., Vendramin, G., Tanzi, E., and Zanetti, A. (1994). Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Engl. J. Med. 330:751-756.
150. Mizorogi, F., Hiramoto, J., Nozato, A., Takekuma, Y., Nagayama, K., Tanaka, T., and Takagi, K. (2000). Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern. Med. 39:112-117.
151. Monteverde, A., Sabattini, E., Poggi, S., Ballare, M., Bertoncelli, M.C., De Vivo, A., Briskomatis, A., Roncador, G., Falini, B., and Pileri, S.A. (1995). Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk. Lymphoma 20:119-124.
152. Monti, G., Galli, M., Invernizzi, F., Pioltelli, P., Saccardo, F., Monteverde, A., Pietrogrande, M., Renoldi, P., Bombardieri, S., Bordin, G., Candela, M., Ferri, C., Gabriella, A., Mazzaro, C., Migliaresi, S., Mussini, C., Ossi, E., Quintiliani, L., Tirri, G., and Vacca, A. (1995). Cryoglobulinaemias: A multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. Qjm 88:115-126.
153. Murai, H., Inaba, S., Kira, J., Yamamoto, A., Ohno, M., and Goto, I. (1995). Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange. Artif. Organs 19:334-338.
154. Muramatsu, T., Hora, K., Ako, S., Tachibana, N., and Tanaka, E. (2000). The role of hepatitis C virus infection in glomerulopathy. Hepatol. Res. 18:190-202.
155. Murphy, A., Dooley, S., Hillary, I.B., and Murphy, G.M. (1993). HCV infection in porphyria cutanea tarda. Lancet 341:1534-1535.
156. Musset, L., Diemert, M.C., Taibi, F., Thi Huong Du, L., Cacoub, P., Leger, J.M., Boissy, G., Gaillard, O., and Galli, J. (1992). Characterization of cryoglobulins by immunoblotting. Clin. Chem. 38:798-802.
157. Naarendorp, M., Kallemuchikkal, U., Nuovo, G.J., and Gorevic, P.D. (2001). Long term efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J. Rheumatol. 28:2466-2473.
158. Nagamine, T., Ohtuka, T., Takehara, K., Arai, T., Takagi, H., and Mori, M. (1996). Thrombocytopenia associated with hepatitis C viral infection. J. Hepatol. 24:135-140.
159. Nagasaka, A., Takahashi, T., Sasaki, T., Takimoto, K., Miyashita, K., Nakamura, M., Wakahama, O., Nishikawa, S., and Higuchi, A. (2001). Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: Host genetic and virological study. J. Med. Virol. 65:52-57.
160. Nemni, R., Sanvito, L., Quattrini, A., Santuccio, G., Camerlingo, M., and Canal, N. (2003). Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J. Neurol. Neurosurg. Psychiatry 74:1267-1271.
161. Ohsawa, M., Shingu, N., Miwa, H., Yoshihara, H., Kubo, M., Tsukuma, H., Teshima, H., Hashimoto, M., and Aozasa, K. (1999). Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int. J. Cancer 80:237-239.
162. Okano, J., Horie, Y., Kawasaki, H., and Kondo, M. (1997). Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology 44:525-528.
163. Origgi, L., Vanoli, M., Carbone, A., Grasso, M., and Scorza, R. (1998). Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am. J. Med. Sci. 315:208-210.
164. Ossi, E., Bordin, M.C., Businaro, M.A., Marson, P., Bonadonna, P., Chiaramonte, M., Boin, F., Valenti, M.T., and Fagiolo, U. (1995). HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin. Exp. Rheumatol. 13(Suppl. 13):S91-S93.
165. Paoletti, V., Donnarumma, L., De Matteis, A., Mammarella, A., Labbadia, G., Musca, A., and Francia, A. (2000). Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med. 42:175-178.
166. Pascual, M., Perrin, L., Giostra, E., and Schifferli, J.A. (1990). Hepatitis C virus in patients with cryoglobulinemia type II. J. Infect. Dis. 162:569-570.
167. Pawlotsky, J.M., Ben Yahia, M., Andre, C., Voisin, M.C., Intrator, L., Roudot-Thoraval, F., Deforges, L., Duvoux, C., Zafrani, E.S., Duval, J., and Dhumeaus, D. (1994). Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 19:841-848.
168. Pawlotsky, J.M., Bouvier, M., Fromont, P., Deforges, L., Duval, J., Dhumeaux, D., and Bierling, P. (1995a). Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J. Hepatol. 23:635-639.
169. Pawlotsky, J.M., Roudot-Thoraval, F., Simmonds, P., Mellor, J., Ben Yahia, M.B., Andre, C., Voisin, M.C., Intrator, L., Zafrani, E.S., Duval, J., and Dhumeaux, D. (1995b). Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. Intern. Med. 122:169-173.
170. Pechere-Bertschi, A., Perrin, L., de Saussure, P., Widmann, J.J., Giostra, E., and Schifferli, J.A. (1992). Hepatitis C: A possible etiology for cryoglobulinaemia type II. Clin. Exp. Immunol. 89:419-422.
171. Perniola, R., De Rinaldis, C., Accogli, E., and Lobreglio, G. (1999). Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients. Ann. Rheum. Dis. 58:698-702.
172. Picerno, I., Di Pietro, A., Spataro, P., Di Benedetto, A., Romano, G., and Scoglio, M.E. (2002). Is diabetes mellitus a risk factor for HCV infection? Ann. Ig. 14:473-477.
173. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G., and Abrignani, S. (1998). Binding of hepatitis C virus to CD81. Science 282:938-941.
174. Polzien, F., Schott, P., Mihm, S., Ramadori, G., and Hartmann, H. (1997). Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia. J. Hepatol. 27:63-71.
175. Popp, J.W., Jr., Dienstag, J.L., Wands, J.R., and Bloch, K.J. (1980). Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann. Intern. Med. 92:379-383.
176. Poynard, T., Cacoub, P., Ratziu, V., Myers, R.P., Dezailles, M.H., Mercadier, A., Ghillani, P., Charlotte, F., Piette, J.C., and Moussalli, J. (2002). Fatigue in patients with chronic hepatitis C. J. Viral Hepat. 9:295-303.
177. Rabkin, C.S., Tess, B.H., Christianson, R.E., Wright, W.E., Waters, D.J., Alter, H.J., and Van Den Berg, B.J. (2002). Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 99:4240-4242.
178. Rajan, S., and Liebman, H.A. (2001). Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am. J. Hematol. 68:202-209.
179. Ramos-Casals, M., Garcia-Carrasco, M., Cervera, R., Rosas, J., Trejo, O., de la Red, G., Sanchez-Tapias, J.M., Font, J., and Ingelmo, M. (2001). Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 80:1-8.
180. Rasul, I., Shepherd, F.A., Kamel-Reid, S., Krajden, M., Pantalony, D., and Heathcote, E.J. (1999). Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 29:543-547.
181. Rieu, V., Cohen, P., Andre, M.H., Mouthon, L., Godmer, P., Jarrousse, B., Lhote, F., Ferriere, F., Deny, P., Buchet, P., and Guillevin, L. (2002). Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41:290-300.
182. Rivera, J., Garcia-Monforte, A., Pineda, A., and Millan Nunez-Cortes, J. (1999). Arthritis in patients with chronic hepatitis C virus infection. J. Rheumatol. 26:420-424.
183. Sabry, A.A., Sobh, M.A., Irving, W.L., Grabowska, A., Wagner, B.E., Fox, S., Kudesia, G., and El Nahas, A.M. (2002a). A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol. Dial. Transplant. 17:239-245.
184. Sabry, A.A., Sobh, M.A., Sheaashaa, H.A., Kudesia, G., Wild, G., Fox, S., Wagner, B.E., Irving, W.L., Grabowska, A., and El-Nahas, A.M. (2002b). Effect of combination therapy (ribavirin and interferon) in HCV-related glomeralopathy. Nephrol. Dial. Transplant. 17:1924-1930.
185. Sacchi, S., Federico, M., Vitolo, U., Boccomini, C., Vallisa, D., Baldini, L., Petrini, M., Rupoli, S., Di Raimondo, F., Merli, F., Liso, V., Tabilio, A., Saglio, G., Vinci, G., Brugiatelli, M., and Dastoli, G. (2001). Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. Haematologica 86:951-958.
186. Sangiorgio, L., Attardo, T., Gangemi, R., Rubino, C., Barone, M., and Lunetta, M. (2000). Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res. Clin. Pract. 48:147-151.
187. Sansonno, D., De Vita, S., Iacobelli, A.R., Comacchiulo, V., Boiocchi, M., and Dammacco, F. (1998). Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J. Immunol. 160:3594-3601.
188. Sansonno, D., De Re, V., Lauletta, G., Tucci, F.A., Boiocchi, M., and Dammacco, F. (2002). Treatment of mixed cryoglobulinemia resistant to interferon-{alpha} with an anti-CD20 monoclonal antibody. Blood. 101:3818-3826.
189. Sansonno, D., De Re, V., Lauletta, G., Tucci, F.A., Boiocchi, M., and Dammacco, F. (2003). Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818-3826.
190. Sasso, E.H., Ghillani, P., Musset, L., Piette, J.C., and Cacoub, P. (2001). Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins. Clin. Exp. Immunol. 123:88-93.
191. Sène, D., Ghillani, P., Thibault, V., Guis, L., Musset, L., Duhaut, P., Piette, J., and Cacoub, P. (2004). Long Term Course of Mixed Cryoglobulinemia in Hepatitis C Virus-Infected patients. J. Rheumatol. (in press).
192. Siersema, P.D., ten Kate, F.J., Mulder, P.G., and Wilson, J.H. (1992). Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence. Liver 12:56-61.
193. Silvestri, F., Barillari, G., Fanin, R., Pipan, C., Falasca, E., Salmaso, F., Zaja, F., Intanti, L., Patriarca, F., Botta, G.A., and Baccarani, M. (1997). Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 82:314-317.
194. Simo, R., Hernandez, C., Genesca, J., Jardi, R., and Mesa, J. (1996). High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 19:998-1000.
195. Sinclair, P.R., Gorman, N., Shedlofsky, S.I., Honsinger, C.P., Sinclair, J.F., Karagas, M.R., and Anderson, K.E. (1997). Ascorbic acid deficiency in porphyria cutanea tarda. J. Lab. Clin. Med. 130:197-201.
196. Stokes, M.B., Chawla, H., Brody, R.I., Kumar, A., Gertner, R., Goldfarb, D.S., and Gallo, G. (1997). Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am. J. Kidney Dis. 29:514-525.
197. Stolzel, U., Kostler, E., Koszka, C., Stoffler-Meilicke, M., Schuppan, D., Somasundaram, R., Doss, M.O., Habermehl, K.O., and Riecken, E.O. (1995). Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500-1503.
198. Stolzel, U., Schuppan, D., Tillmann, H.L., Manns, M.P., Tannapfel, A., Doss, M.O., Zimmer, T., and Kostler, E. (2002). Autoimmunity and HCV infection in porphyria cutanea tarda: A controlled study. Cell Mol. Biol. (Noisy-le-grand) 48:43-47.
199. Suzuki, H., Takei, T., Tsuji, H., and Nishikawa, T. (2000). Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. Intern. Med. 39:397-400.
200. Takikawa, H., Yamazaki, R., Shoji, S., Miyake, K., and Yamanaka, M. (1995). Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda. J. Hepatol. 22:249-250.
201. Tannapfel, A., Stolzel, U., Kostler, E., Melz, S., Richter, M., Keim, V., Schuppan, D., and Wittekind, C. (2001). C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients. Virchows Arch. 439:1-5.
202. Tarantino, A., Campise, M., Banfi, G., Confalonieri, R., Bucci, A., Montoli, A., Colasanti, G., Damilano, I., D'Amico, G., and Minetti, L. (1995). Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 47:618-623.
203. Thuluvath, P.J., and John, P.R. (2003). Association between hepatitis C, diabetes mellitus, and race. A case-control study. Am. J. Gastroenterol. 98:438-441.
204. Tissot, J.D., Schifferli, J.A., Hochstrasser, D.F., Pasquali, C., Spertini, F., Clement, F., Frutiger, S., Paquet, N., Hughes, G.J., and Schneider, P. (1994). Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J. Immunol. Methods 173:63-75.
205. Trejo, O., Ramos-Casals, M., Garcia-Carrasco, M., Yague, J., Jimenez, S., de la Red, G., Cervera, R., Font, J., and Ingelmo, M. (2001). Cryoglobulinemia: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80:252-262.
206. Tridon, A., Abergel, A., Kuder, P., Henquell, C., Malaure, H., Dibet, P., Ghrib, J., Bommelaer, G., and Betail, G. (1997). Mixed cryoglobulins and autoimmunity in hepatitis C. Pathol. Biol. (Paris) 45:291-297.
207. Tsukazaki, N., Watanabe, M., and Irifune, H. (1998). Porphyria cutanea tarda and hepatitis C virus infection. Br. J. Dermatol. 138:1015-1017.
208. Uygun, A., Kadayifci, A., Ercin, N., Bagci, S., and Dagalp, K. (2000). Interferon treatment for thrombocytopenia associated with chronic HCV infection. Int. J. Clin. Pract. 54:683-684.
209. Vallisa, D., Berte, R., Rocca, A., Civardi, G., Giangregorio, F., Ferrari, B., Sbolli, G., and Cavanna, L. (1999). Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am. J. Med. 106:556-560.
210. Verbaan, H., Carlson, J., Eriksson, S., Larsson, A., Liedholm, R., Manthorpe, R., Tabery, H., Widell, A., and Lindgren, S. (1999). Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J. Intern. Med. 245:127-132.
211. Zachou, K., Liaskos, C., Christodoulou, D.K., Kardasi, M., Papadamou, G., Gatselis, N., Georgiadou, S.P., Tsianos, E.V., and Dalekos, G.N. (2003). Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur. J. Clin. Invest. 33:161-168.
212. Zaltron, S., Puoti, M., Liberini, P., Antonini, L., Quinzanini, M., Manni, M., Forleo, M.A., Rossi, S., Spinetti, A., Zanini, B., and Carosi, G. (1998). High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital. J. Gastroenterol. Hepatol. 30:391-395.
213. Zignego, A.L., Ferri, C., Giannini, C., La Civita, L., Careccia, G., Longombardo, G., Bellesi, G., Caracciolo, F., Thiers, V., and Gentilini, P. (1997). Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: Evidence for a pathogenetic role. Arch Virol. 142:545-555.
214. Zignego, A.L., Ferri, C., Giannini, C., Monti, M., La Civita, L., Careccia, G., Longombardo, G., Lombardini, F., Bombardieri, S., and Gentilini, P. (1996). Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann. Intern. Med. 124:31-34.
215. Zignego, A.L., Giannelli, F., Marrocchi, M.E., Mazzocca, A., Ferri, C., Giannini, C., Monti, M., Caini, P., Villa, G.L., Laffi, G., and Gentilini, P. (2000). t(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31:474-479.
216. Zignego, A.L., Ferri, C., Giannelli, F., Giannini, C., Caini, P., Monti, M., Marrocchi, M.E., Di Pietro, E., La Villa, G., Laffi, G., and Gentilini, P. (2002). Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann. Intern. Med. 137:571-580.
217. Zuckerman, E., Keren, D., Slobodin, G., Rosner, I., Rozenbaum, M., Toubi, E., Sabo, E., Tsykounov, I., Naschitz, J.E., and Yeshurun, D. (2000). Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J. Rheumatol. 27:2172-2178.
218. Zuckerman, E., Yeshurun, D., and Rosner, I. (2001). Management of hepatitis C virus-related arthritis. BioDrugs 15:573-584.
219. Zuckerman, E., Zuckerman, T., Levine, A.M., Douer, D., Gutekunst, K., Mizokami, M., Qian, D.G., Velankar, M., Nathwani, B.N., and Fong, T.L. (1997). Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann. Intern. Med. 127:423-428.